Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066

Watchlist Manager
Shandong Weigao Group Medical Polymer Co Ltd Logo
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Watchlist
Price: 4.4 HKD -2.87% Market Closed
Market Cap: 19.9B HKD
Have any thoughts about
Shandong Weigao Group Medical Polymer Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Shandong Weigao Group Medical Polymer Co Ltd

Wall Street analysts forecast Shandong Weigao Group Medical Polymer Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shandong Weigao Group Medical Polymer Co Ltd is 6.79 HKD with a low forecast of 5.15 HKD and a high forecast of 8.4 HKD.

Lowest
Price Target
5.15 HKD
17% Upside
Average
Price Target
6.79 HKD
54% Upside
Highest
Price Target
8.4 HKD
91% Upside
Shandong Weigao Group Medical Polymer Co Ltd Competitors:
Price Targets
BVS
Bioventus Inc
28% Upside
HAE
Haemonetics Corp
32% Upside
STAA
STAAR Surgical Co
64% Upside
300888
Winner Medical Co Ltd
8% Upside
TOPGLOV
Top Glove Corporation Bhd
4% Downside
AP4
Riverstone Holdings Ltd
12% Upside
300595
Autek China Inc
24% Upside
7730
Mani Inc
34% Upside

Revenue
Forecast

Revenue Estimate
Shandong Weigao Group Medical Polymer Co Ltd

For the last 8 years the compound annual growth rate for Shandong Weigao Group Medical Polymer Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 6%.

11%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Shandong Weigao Group Medical Polymer Co Ltd

For the last 8 years the compound annual growth rate for Shandong Weigao Group Medical Polymer Co Ltd's operating income is 7%. The projected CAGR for the next 3 years is 9%.

7%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Shandong Weigao Group Medical Polymer Co Ltd

For the last 8 years the compound annual growth rate for Shandong Weigao Group Medical Polymer Co Ltd's net income is 8%. The projected CAGR for the next 3 years is 8%.

8%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shandong Weigao Group Medical Polymer Co Ltd's stock price target?
Price Target
6.79 HKD

According to Wall Street analysts, the average 1-year price target for Shandong Weigao Group Medical Polymer Co Ltd is 6.79 HKD with a low forecast of 5.15 HKD and a high forecast of 8.4 HKD.

What is Shandong Weigao Group Medical Polymer Co Ltd's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Shandong Weigao Group Medical Polymer Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 6%.

What is Shandong Weigao Group Medical Polymer Co Ltd's Operating Income forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Shandong Weigao Group Medical Polymer Co Ltd's operating income is 7%. The projected CAGR for the next 3 years is 9%.

What is Shandong Weigao Group Medical Polymer Co Ltd's Net Income forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Shandong Weigao Group Medical Polymer Co Ltd's net income is 8%. The projected CAGR for the next 3 years is 8%.

Back to Top